Jan. 3, 2023 – An article recently published in the journal Biological Psychiatry discusses the findings of researchers at the Rutgers Brain Health Institute and other institutions on the role of the orexin system in drug addiction. The orexin system, which regulates sleep patterns, reward pathways, and mood, has been found to drive drug-seeking behavior. It has been observed that many drugs of abuse increase orexin production in both human and animal brains, and blocking this system can reverse addiction in animals. In addition, a separate study has shown that one of the three FDA-approved insomnia medications that block orexin can reduce opioid cravings in human subjects.
“There’s still much to discover about how orexin drives drug craving, but we know more than enough to justify testing orexin antagonists in clinical trials as addiction treatments,” said Gary Aston-Jones, coauthor of the review and director of the Brain Health Institute. “We’re applying for funding from the National Institutes of Health and looking to hire a physician-scientist with clinical trial experience to lead these efforts.”
GIVING BACK IN STYLE – April 17, 2024 - “It’s still one day at…
RIDING THE WAVE...CALMLY – April 18, 2024 - “I was 13 years old and…
VIDEO – NEW YORK STORIES – April 23, 2024 - Sara Gettelfinger had steadily…
TRY IT, YOU’LL LIKE IT – April 18, 2024 - The rise in “sober…
AUDIO – SOBER MEN CAN DO THAT – April 4, 2024 - Acting icon…
I’LL BET HE GOES TO GA (not Georgia) – April 13, 2024 -The initial…